Effect of chronic m-CPP on locomotion, hypophagia, plasma corticosterone and 5-HT(2C) receptor levels in the rat

British Journal of Pharmacology

Volumn 123, Issue 8, 1998, Pages 1707-1715

  Fone, Kevin C F ^a   Austin, Rachel H ^a   Topham, Ian A ^a   Kennett, Guy A ^b   Punhani, Taniya ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

Author keywords

5 hydroxytryptamine(2C) antibodies; 5 hydroxytryptamine(2C) receptors; Anxiety; Corticosterone; Hypolocomotion; Hypophagia

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; CORTICOSTERONE; MESULERGINE; SEROTONIN 2C RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CORTICOSTERONE BLOOD LEVEL; DOSE RESPONSE; DRUG INFUSION; DRUG TOLERANCE; FOOD INTAKE; HIPPOCAMPUS; HYPOPHAGIA; HYPOTHALAMUS; INTRAPERITONEAL DRUG ADMINISTRATION; LIMBIC CORTEX; LOCOMOTION; MALE; MEMBRANE BINDING; NONHUMAN; NUCLEUS ACCUMBENS; OCCIPITAL CORTEX; OPEN FIELD BEHAVIOR; PARIETAL LOBE; PRIORITY JOURNAL; RADIOIMMUNOASSAY; RAT; RECEPTOR DOWN REGULATION; SUBCUTANEOUS DRUG ADMINISTRATION; TEMPORAL CORTEX;

ANIMALS; CEREBRAL CORTEX; CORTICOSTERONE; DOWN-REGULATION; EATING; HABITUATION, PSYCHOPHYSIOLOGIC; HIPPOCAMPUS; MALE; MOTOR ACTIVITY; PIPERAZINES; RATS; RECEPTORS, SEROTONIN; SEROTONIN AGONISTS;

EID: 0031894597     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0701798     Document Type: Article

References (55)

1. 2C receptor-mediated oxytocin, prolactin and ACTH/corticosterone responses. Behav. Brain Res., 73, 277-280.
2. 2 receptor subtypes: a family re-united? Trends Pharmacol. Sci., 16, 105-110.
3. 1C receptor mediated behaviour in rats following chronic treatment with 5-HT receptor agonists, antagonists or anti-depressants. Psyhopharmacology, 105, 219-224.
4. 2 binding site after chronic administration of agonists and antagonists. Neuropharmacology, 25, 1267-1271.
5. 2C receptor antagonist. Neuropharmacology, 36, 621-629.
6. 7; molecular pharmacology of adenylate-cyclase stimulating receptors. Seminars Neurosci., 7, 375-382.
7. BURNS, C.M., CHU, H., RUETER, S.M., HUTCHINSON, L.K., CANTON, H., SANDERSBUSH, E. & EMESON, R.B. (1997). Regulation of serotonin-2C receptor G-protein coupling by RNA editing. Nature, 387, 303-308.
8. CALOGERA, A.E., BAGDY, G., SZEMEREDI, K., TARTAGLIA, M.E., GOLD, P.W. & CHROUSOS, G.P. (1990). Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat. Endocrinology, 126, 1888-1894.
9. 2C receptor produced by alternative splicing. Mol. Pharmacol., 50, 799-807.
10. COHEN, R.M., AULAKH, C.S. & MURPHY, D.L (1983). Long-term clorgyline treatment antagonizes the eating and motor function responses to m-chlorophenylpiperazine. Eur. J. Pharmacol., 94, 175-179.
11. 1C receptors. Trends Pharmacol. Sci., 11, 181-182.
12. 2 receptors in rat brain. Neuropsychopharmacology, 2, 81-87.
13. 1A agonist flesinoxan on hypothalamic neuropeptide Y in the rat: evidence that NPY may mediate serotonin's effects on food intake. Peptides, 17, 943-949.
14. 2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats. Br. J. Pharmacol., 96, 599-608.
15. FONE, K.C.F., ROBINSON, A.J. & MARSDEN, C.A. (1991). Characterization of the 5-HT receptor subtypes involved in the motor behaviours produced by intrathecal administration of 5-HT agonists in rats. Br. J. Pharmacol., 103, 1547-1555.
16. 2C receptor responsiveness occurs on rearing rats in social isolation. Psychopharmacologv, 123, 346-352.
17. 2C receptors. Br. J. Pharmacol., 107, 7P.
18. FREO, U., HOLLOWAY, H.W., GREIG, N.H. & SONCRANT, T.T. (1992). Chronic treatment with meta-chlorophcnylpiperazine (m-CPP) alters behavioral and cerebral metabolic responses to the serotonin agonists m-CPP and quipazine but not 8-hydroxy-2(di-N-propylamino)tetralin. Psychopharmacology, 107, 30-38.
19. 1 recognition sites. J. Receptor Res., 8, 59-81.
20. HOYER, D., CLARKE, D.E., FOZARD, J.R., HARTIG, P.R., MARTIN, G.R., MYLECHARRANE, E.J., SAXENA, P.R. & HUMPHREY, P.P.A. (1994). International Union of Pharmacology classification of receptors for 5-hydroxytryptamine (serotonin). Pharmacol. Rev., 46, 157-204.
21. HOYER, D. & MARTIN, G. (1997). 5-HT receptor classification and nomenclature: towards a harmonization with the human genome. Neuropharmacology, 36, 419-428.
22. 1C receptor binding sites in Wistar rat brain. Eur. J. Pharmacol., 263, 213-216.
23. JULIUS, D., MACDERMOTT, A.B., AXEL, R. & JESSELL, T.M. (1988). Molecular characterisation of a functional cDNA encoding the serotonin 1C receptor. Science, 241, 558-564.
24. KENNEDY, A.J., GIBSON, E.L., O'CONNELL, M.T. & CURZON, G. (1993). Effects of housing, restraint and chronic treatments with mCPP and sertraline on behavioural responses to mCPP. Psychopharmacology, 113, 262-268.
25. 1c receptor antagonists have anxiolytic-like actions in the rat social interaction model. Psychopharmacology, 107, 379-384.
26. 1C receptors and their therapeutic relevance. Curr. Opin. Invest. Drugs., 2, 317-362.
27. 2B receptor antagonist, in 2 conflict models of anxiety. Psychopharmacology, 118, 178-182.
28. 1C receptors. Br. J. Pharmacol., 94, 137-147.
29. 1B agonists induce anorexia at a postsynaptic site. Eur. J. Pharmacol., 141, 429-435.
30. 2C receptor antagonist. Neuropharmacology, 36, 609-620.
31. LEIBOWITZ, S.C., WEISS, G.F. & SJOR-PONSER, G. (1988). Hypothalamic serotonin: pharmacological, biochemical and behavioural analyses of its feeding suppressive action. Clin. Neuropharmacol, 11, 551-571.
32. 2 receptors by DOM treatment. Eur. J. Pharmacol., 163, 145-149.
33. LOHSE, M.J. (1993). Molecular mechanisms of membrane receptor desensitization. Biochem. Biophys. Acta, 1179, 171-188.
34. LUCAS, J.J. & HEN, R. (1995). New players in the 5-HT receptor field: genes and knockouts. Trends Pharmacol Sci., 16, 246-252.
35. LUCKI, I., WARD, H.R. & FRAZER, A. (1989). Effect of 1-(m-chlorophenyl)piperazine and 1-(m-trifluoromethylphenyl)piperazine on locomotor activity. J. Pharmacol. Exp. Ther., 249, 155-164.
36. 2C Cys23Ser polymorphism. NeuroReport, 7, 2100-2102.
37. 2A/2C receptor antagonists. PsYchopharmacology, 130, 144-151.
38. 1C receptor mRNA in the rodent brain examined by in situ hybridisation histochemistry: comparison with receptor binding distribution. Neuroscience, 35, 577-591.
39. MURPHY, D.L., LESCH, K.P., AULAKH, C.S. & PIGOTT, T.A. (1991). III. Serotonin-selective arylpiperazines with neuroendocrine, behavioral, temperature, and cardiovascular effects in humans. Pharmacol. Rev., 43, 527-552.
40. PAZOS, A., HOYER, D. & PALACIOS, J.M. (1984). The binding of serotonergic ligands to the porcine choroid plexus: characterisation of a new type of serotonin recognition site. Eur. J. Pharmacol., 106, 539-546.
41. PAZOS, A. & PALACIOS, J.M. (1985). Quantitative autoradiographic mapping of serotonin receptors in the rat brain I: Serotonin I receptors. Brain Res., 346, 205-230.
42. 2C receptors. Mol. Brain Res., 23, 163-178.
43. 1C binding sites in the rat -characterization of [H-3]mesulergine binding. J. Pharmacol. Exp. Ther., 261, 161-165.
44. 1C/2 receptor agonists and antagonists. Eur. J. Pharmacol., 244, 1-5.
45. ROCHA, B., DI SCALA, G., RICO, M., HOYER, D. & SANDNER, G. (1993). Effect of 5,7-dihydroxytryptamine lesion on mianserin-induced conditioned place aversion and on 5-hydroxytryptamine1C receptors in the rat brain. Neuroscience, 56, 687-693.
46. SAMANIN, R., MENNINI, T., FERRARIS, A., BENDOTTI, C., BORSINI, F. & GARATTINI, S. (1979). m-Chlorophenylpiperazine: a central serotonin agonist causing powerful anorexia in rats. Naunyn-Schmiedeberg's Arch. Pharmacol., 308, 159-163.
47. SANDERS-BUSH, E. & BREDDING, M. (1988). Putative selective 5-HT-2 antagonists block serotonin 5-HT-1C receptors in the choroid plexus. J. Pharmacol. Exp. Ther., 247, 169-173.
48. 1C receptor reserve in choroid plexus masks receptor subsensitivity. J. Pharmacol. Exp. Ther., 252, 984-988.
49. 2C receptor protein in adult rat brain and spinal cord determined using a receptor-directed antibody: effect of 5,7-dihydroxytryptamine. Synapse, 26, 45-56.
50. SILLS, M.A., LUCKI, I. & FRAZER, A. (1985). Development of selective tolerance to the serotonin behavioural syndrome and suppression of locomotor activity after repeated administration of either 5-MeODMT or m-CPP. Life Sci., 36, 2463-2469.
51. 2C receptorgene. NeuroReport. 7, 169-172.
52. SUCKOW, R.F., COOPER, T.B. & KAHN, R.S. (1990). High-performance liquid chromatographic method for the analysis of plasma m-chlorophenylpiperazine. J. Chromatog., 528, 228-234.
53. ULRICHSEN, J., PARTILLA, J.S. & DAX, E.M. (1992). Long-term administration of m-chlorophenylpiperazine (mCPP) to rats induces changes in serotonin receptor binding, dopamine levels and locomotor activity without altering prolactin and corticosterone secretion. Psychopharmacology, 107, 229-235.
54. WILKINSON, L.O. & DOURISH, C.T. (1991). Serotonin and animal behaviour. In Serotonin Receptor Subtypes and Clinical Aspects. ed. pp. 147-210. New York: Wiley-Liss Inc.
55. 2C receptor - complete cDNA, genomic structure, and alternatively spliced variant. Genomics, 35, 551-561.